Sign inJoin waitlistJoin the waitlist

Celina Kleer

Co-Director, Breast Pathology · University of Michigan

Credentials: · · ·

History

Breast Pathology · University of Michigan
Present
University of Michigan
Present
University of Michigan
Present

University of Michigan
1997–1998
Pathology
Mayo Clinic
1993–1997
University of Michigan Medical School
1989–1993

Research

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Cell stem cell · 2007 · 3,200 citations
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
Proceedings of the National Academy of Sciences of the United States of America · 2003 · First of 15 authors · Corresponding · 1,375 citations
Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity
Cell · 2013 · 714 citations

Sofia Merajver
39 papers
Michael Sabel
24 papers
LN
Lisa Newman
16 papers
DH
Daniel Hayes
15 papers
MW
Max Wicha
12 papers
Yanhong Zhang
10 papers
AC
Alfred Chang
9 papers
AS
Anne Schott
8 papers
Judy Pang
8 papers
TA
Talha Anwar
8 papers · 3 as a resident
VC
Vincent Cimmino
8 papers
Boris Burman
6 papers

Grants

Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer
National Cancer Institute · R01
Contact PI · $5.5M · University of Michigan at Ann Arbor
2008–2031
Role of EZH2 in Breast Cancer Progression
National Cancer Institute · R01
Contact PI · $5.9M · University of Michigan at Ann Arbor
2005–2028
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)
National Cancer Institute · R01
PI · $1.2M · University of Michigan at Ann Arbor
2020–2027
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af
National Cancer Institute · U01
Contact PI · $1.7M · University of Michigan at Ann Arbor
2010–2015